BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,776,497 | +183.2% | 109,613 | +245.7% | 0.01% | +400.0% |
| Q1 2024 | $980,411 | -43.0% | 31,708 | -51.4% | 0.00% | -75.0% |
| Q3 2023 | $1,721,223 | -6.6% | 65,272 | -39.1% | 0.00% | -33.3% |
| Q2 2023 | $1,842,550 | +557.6% | 107,125 | +533.9% | 0.01% | +50.0% |
| Q1 2023 | $280,202 | -68.3% | 16,900 | -68.1% | 0.00% | -85.2% |
| Q4 2021 | $883,000 | +244.9% | 52,953 | +1174.1% | 0.03% | +80.0% |
| Q1 2021 | $256,000 | – | 4,156 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
| M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
| GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
| Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
| HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
| Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
| Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |